CTIS.eu › Cities › France › Paris Cedex 18
Paris Cedex 18
France
258 total trials
103 recruiting
2022-502099-22-00
5
HIV-1 Infection
2022-502126-40-00
5
HIV-1 infection
2022-502127-22-00
5
HIV-1 Infection
2024-511807-41-00
5
Hemophagocytic lymphohistiocytosis (HLH)
2024-512754-16-00
5
Prostate cancer
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2023-510075-63-00
5
Patients with ventilator-associated tracheobronchitis
2024-511807-41-01
5
Hemophagocytic lymphohistiocytosis (HLH)
2024-512763-32-00
5
Patients diagnosed at the study sites with rifampicinresistant
tubercu
2024-514246-37-00
4
Idiopathic pulmonary fibrosis (IPF)
2024-515714-40-00
4
Gout adult patients
2024-515834-34-00
5
complicated acute appendicitis
2024-515956-19-00
5
Chondrocalcinosis
2024-516018-39-00
5
Erythema multiforme (EM) in its severe form managed at the hospital
2024-516167-86-00
5
Patients referred for an isolated or a combined surgical correction of
2024-516215-24-00
4
TAkayasu ARteritiS
2024-516232-10-00
6
Serious infections in critically ill patients treated with antibiotics
2024-516849-39-01
5
antibiotic therapy in Sepsis
2024-517710-15-00
4
thrombocytopenic patients undergoing cardiac surgery
2024-518013-25-00
4
Idiopathic Pulmonary Fibrosis
2024-518018-22-00
5
staphylococcal endocarditis
2024-520089-70-00
5
Cutaneous lupus erythematosus
2024-520140-42-00
5
Patients with primary HPV high-grade squamous intra-epithelial lesions
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms
Showing 1–24 of 258 trials